Masaru Kanekiyo

1. Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
   2022/11/02 by Meagan McMahon, George O’Dell, Jessica Tan +16 · 1 voice · 2 citations
   Medicine · #Influenza Virus Research Studies #Respiratory viral infections research #SARS-CoV-2 and COVID-19 Research
2. From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks
   2025/11/03 by Cyrus M. Haas, Naveen Jasti, Annie Dosey +8 · 2 voices · 1 citation
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Biochemical and Structural Characterization #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches
3. Pre-exposure antibody prophylaxis protects macaques from severe influenza
   2025/01/30 by Masaru Kanekiyo, Rebecca A. Gillespie, Kristine Cooper +33 · 2 voices · 1 citation
   Agricultural and Biological Sciences · Medicine · #Animal Disease Management and Epidemiology #Influenza Virus Research Studies #Respiratory viral infections research